title: Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?
authors.affiliation: University College London Hospital, London, UK.
authors.forename: Chris
authors.initials: C
authors.lastname: Poullis
authors.affiliation: Guys Hospital, London, UK.
authors.forename: Majid
authors.initials: M
authors.lastname: Shabbir
authors.affiliation: St James' Hospital, Leeds, UK.
authors.forename: Ian
authors.initials: I
authors.lastname: Eardley
authors.affiliation: Memorial Sloan Kettering, New York, NY, USA.
authors.forename: John
authors.initials: J
authors.lastname: Mulhall
authors.affiliation: University College London Hospital, London, UK.
authors.forename: Suks
authors.initials: S
authors.lastname: Minhas
mesh_terms: D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D003012:Microbial Collagenase / Q000008:administration & dosage / Q000627:therapeutic use*; D010411:Penile Induration / Q000188:drug therapy* / Q000503:physiopathology; D020127:Recovery of Function; D016896:Treatment Outcome
chemical_list: D003012:Microbial Collagenase